Data published in JAMA Network Open suggest that prescribing practices for ART in pregnant women living with HIV in the US do not align optimally with national guidelines.
Alendronate treatment is well-tolerated and improved bone mineral density (BMD) with no safety concerns in children and adolescents with perinatally acquired HIV.
According to the United States Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report, preliminary data from 2017 show that gay, bisexual, and other men who have sex with men accounted for 67% of incident diagnoses of HIV.
Of the estimated 38,739 new cases of HIV reported in 2017, 70% were among men who have sex with men. Use of daily PrEP can virtually eliminate the risk of developing HIV, if used as prescribed.
Researchers examined the prevalence of HIV drug resistance patterns among HIV-infected infants using 3 nationally representative surveys in South Africa that evaluated the effectiveness of national programs to prevent mother-to-child transmission of HIV.
Approximately 1 in 5 people with HIV also has prevalent DM, and control of hemoglobin A1c levels in these patients may have a beneficial effect on CD4 counts.
